Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 164.71%117.28M | ---- | -248.64%-181.23M | ---- | 69.76%121.92M | ---- | -80.67%71.82M | ---- | 54.57%371.47M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -141.65%-18.34M | ---- | -83.00%-7.59M | ---- | -233.44%-4.15M | ---- | ---1.24M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50K |
| Impairment and provisions: | ---- | -57.12%179.95M | ---- | 131.55%419.67M | ---- | 19.88%181.24M | ---- | 3,149.30%151.19M | ---- | -51.87%4.65M |
| -Impairmen of inventory (reversal) | ---- | 1.87%20.38M | ---- | -44.52%20M | ---- | --36.05M | ---- | ---- | ---- | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --63.98M | ---- | ---- |
| -Other impairments and provisions | ---- | -60.07%159.57M | ---- | 175.27%399.67M | ---- | 66.47%145.19M | ---- | 1,774.38%87.22M | ---- | -51.87%4.65M |
| Revaluation surplus: | ---- | 57.25%-657K | ---- | 63.57%-1.54M | ---- | 90.53%-4.22M | ---- | -67.84%-44.53M | ---- | 15.81%-26.53M |
| -Other fair value changes | ---- | 57.25%-657K | ---- | 63.57%-1.54M | ---- | 90.53%-4.22M | ---- | -67.84%-44.53M | ---- | 15.81%-26.53M |
| Asset sale loss (gain): | ---- | -98.44%24K | ---- | 102.43%1.54M | ---- | -218,100.00%-63.28M | ---- | ---29K | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---63.28M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -98.44%24K | ---- | --1.54M | ---- | ---- | ---- | ---29K | ---- | ---- |
| Depreciation and amortization: | ---- | 14.08%88.71M | ---- | 7.82%77.76M | ---- | -17.27%72.12M | ---- | 65.07%87.18M | ---- | 28.07%52.81M |
| -Depreciation | ---- | 16.45%65.79M | ---- | 10.06%56.5M | ---- | 25.33%51.33M | ---- | --40.96M | ---- | ---- |
| -Amortization of intangible assets | ---- | 16.87%10.64M | ---- | 60.42%9.11M | ---- | -64.63%5.68M | ---- | 5.64%16.05M | ---- | 96.23%15.19M |
| Financial expense | ---- | -27.28%965K | ---- | -55.94%1.33M | ---- | -62.90%3.01M | ---- | 1,154.87%8.12M | ---- | --647K |
| Exchange Loss (gain) | ---- | 155.99%1.54M | ---- | -114.12%-2.75M | ---- | 1,427.65%19.45M | ---- | --1.27M | ---- | ---- |
| Special items | ---- | 25.84%1.24M | ---- | -93.98%983K | ---- | -34.48%16.33M | ---- | 182.18%24.93M | ---- | 2,526.65%8.83M |
| Operating profit before the change of operating capital | ---- | 20.29%370.7M | ---- | -10.00%308.18M | ---- | 14.64%342.43M | ---- | -27.49%298.71M | ---- | 62.69%411.93M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -101.26%-694K | ---- | 120.60%55.15M | ---- | 147.86%25M | ---- | 1.61%-52.23M | ---- | -1,289.69%-53.09M |
| Accounts receivable (increase)decrease | ---- | 64.32%-24.58M | ---- | -322.08%-68.89M | ---- | 117.12%31.02M | ---- | 39.91%-181.16M | ---- | -2,516.13%-301.46M |
| Accounts payable increase (decrease) | ---- | 237.55%14.03M | ---- | 109.31%4.16M | ---- | 66.97%-44.64M | ---- | -181.60%-135.16M | ---- | 9,342.93%165.63M |
| prepayments (increase)decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,332.92%-105.11M |
| Special items for working capital changes | ---- | -88.74%8.53M | ---- | 497.48%75.8M | ---- | -85.79%12.69M | ---- | 72.01%89.27M | ---- | -8.22%51.9M |
| Cash from business operations | ---- | -1.71%367.99M | ---- | 2.16%374.39M | ---- | 1,786.70%366.49M | ---- | -88.56%19.43M | ---- | -45.72%169.81M |
| Other taxs | ---- | -13.25%-564K | ---- | 98.13%-498K | ---- | 37.78%-26.65M | ---- | -815.02%-42.83M | ---- | 87.46%-4.68M |
| Special items of business | 71.19%-37.18M | ---- | -9.20%-129.04M | ---- | 17.50%-118.16M | ---- | 48.38%-143.22M | ---- | ---277.46M | ---- |
| Net cash from operations | 71.19%-37.18M | -1.73%367.43M | -9.20%-129.04M | 10.02%373.9M | 17.50%-118.16M | 1,551.88%339.84M | 48.38%-143.22M | -114.18%-23.41M | -63.40%-277.46M | -40.06%165.13M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -10.67%5.09M | 82.73%8.61M | 161.02%5.7M | 405.14%4.71M | 404.16%2.18M | -25.00%933K | --433K | --1.24M | ---- | ---- |
| Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | 103.02%12.68M | ---- | ---420M | ---420M | ---- |
| Decrease in deposits (increase) | -204.85%-100M | 134.60%115.31M | --95.38M | ---333.31M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | --41K | ---- | ---- | ---- | ---- | ---- | --77K | --48K | ---- |
| Purchase of fixed assets | -12.09%-72.76M | 57.76%-107.37M | 59.61%-64.92M | -236.89%-254.16M | -205.52%-160.72M | 78.78%-75.44M | 56.63%-52.61M | -282.39%-355.54M | -169.02%-121.28M | -9.46%-92.98M |
| Purchase of intangible assets | 0.00%-237K | 99.47%-236K | 99.47%-237K | -38.25%-44.74M | -150.51%-44.31M | -1,585.47%-32.36M | -4,518.02%-17.69M | -203.80%-1.92M | 29.85%-383K | 98.32%-632K |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---157.37M | ---155.62M | ---- |
| Recovery of cash from investments | 19.95%799.8M | -12.70%1.65B | -47.44%666.77M | 28.00%1.89B | 63.49%1.27B | -38.14%1.48B | -46.86%775.95M | 119.38%2.39B | 487.54%1.46B | 36.16%1.09B |
| Cash on investment | -63.98%-866.32M | 10.10%-1.62B | 49.51%-528.31M | -32.66%-1.8B | -317.71%-1.05B | 37.47%-1.36B | 79.25%-250.5M | -99.85%-2.17B | -1,640.43%-1.21B | -19.87%-1.09B |
| Other items in the investment business | ---- | -16.67%25M | ---- | -64.59%30M | ---- | 4,725.34%84.73M | --34.73M | --1.76M | ---- | ---- |
| Net cash from investment operations | -234.43%-234.42M | 115.26%76.79M | 798.19%174.38M | -543.07%-503.19M | -96.04%19.42M | 116.01%113.57M | 210.40%490.32M | -698.17%-709.5M | -432.27%-444.12M | -48.52%-88.89M |
| Net cash before financing | -698.96%-271.61M | 443.57%444.22M | 145.92%45.35M | -128.52%-129.3M | -128.45%-98.75M | 161.86%453.41M | 148.10%347.1M | -1,061.38%-732.91M | -1,896.12%-721.58M | -64.65%76.24M |
| Cash flow from financing activities | ||||||||||
| Refund | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---32M |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.29B |
| Dividends paid - financing | -0.30%-90.61M | -98.34%-90.34M | ---90.34M | 73.92%-45.55M | ---- | 9.97%-174.62M | 24.17%-84.57M | ---193.95M | ---111.52M | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | -2,763.45%-8.3M | -8.59%-8.3M | 99.50%-290K | -1,657.93%-7.65M | -6,586.74%-57.97M |
| Other items of the financing business | ---- | ---- | ---- | ---- | ---- | 49.30%-17.63M | ---17.63M | ---34.78M | ---- | ---- |
| Net cash from financing operations | 2.55%-90.61M | -86.40%-95.5M | -2,450.25%-92.98M | 74.90%-51.23M | 96.71%-3.65M | 23.68%-204.1M | 9.82%-110.86M | -122.35%-267.43M | -278.99%-122.92M | 877.36%1.2B |
| Effect of rate | -83.17%264K | ---- | 235.26%1.57M | 42.81%1.7M | -72.29%468K | -70.60%1.19M | 301.55%1.69M | 104.78%4.04M | -578.86%-838K | -12,110.21%-84.67M |
| Net Cash | -660.38%-362.21M | 293.17%348.73M | 53.48%-47.64M | -172.41%-180.53M | -143.34%-102.39M | 124.92%249.31M | 127.97%236.24M | -178.59%-1B | -1,131.34%-844.5M | 1,962.85%1.27B |
| Begining period cash | 101.95%690.77M | -34.33%342.04M | -34.33%342.04M | 108.39%520.87M | 66.75%520.87M | -80.90%249.95M | -76.13%312.37M | 986.20%1.31B | 986.20%1.31B | 107.47%120.48M |
| Items Period | ---- | ---- | ---- | ---- | ---7M | --20.42M | ---- | ---- | ---- | ---- |
| Cash at the end | 11.10%328.82M | 101.95%690.77M | -28.15%295.98M | -34.33%342.04M | -25.14%411.95M | 66.75%520.87M | 18.77%550.3M | -76.13%312.37M | 789.78%463.33M | 986.20%1.31B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.